Skip to main content
Patent
Medicine
Pharma

Health Care at Reasonable Cost: Protecting the Hatch-Waxman Act from Anticompetitive Gaming

This episode is audio from the Protecting the Hatch-Waxman Act from Anticompetitive Gaming panel from the Engelberg Center’s Hatch-Waxman at 40 and Beyond Symposium. It was recorded on September 26, 2024.

Anisha Dasgupta, Federal Trade Commission

Henry Hadad, Bristol-Myers Squibb

Steve Shadowen, Hilliard Shadowen LLP

Eric Stock, Gibson, Dunn & Crutcher LLP

Scott Hemphill, Engelberg Center on Innovation Law & Policy, NYU School of Law (moderator)